{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:21:35Z","timestamp":1789154495814,"version":"build-2803163510"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"DOI":"10.7759\/cureus.79868","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:29:37Z","timestamp":1740821377000},"source":"Crossref","is-referenced-by-count":1,"title":["Intravenous Iron (III) Hydroxide Polymaltose Complex Infusion Related Severe Prolonged Hypophosphatemia"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Aljaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01770-2","article-title":"Intravenous iron-induced hypophosphatemia: an emerging syndrome","volume":"38","author":"Glaspy JA","year":"2021","unstructured":"Glaspy JA, Wolf M, Strauss WE. Intravenous iron-induced hypophosphatemia: an emerging syndrome. Adv Ther. 2021, 38:3531-49. 10.1007\/s12325-021-01770-2","journal-title":"Adv Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer B","year":"2022","unstructured":"Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H. Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management. Bone. 2022, 154:116202. 10.1016\/j.bone.2021.116202","journal-title":"Bone"},{"key":"ref3","unstructured":"FGF23 gene. (2024). Accessed. March 31, 2024: https:\/\/medlineplus.gov\/genetics\/gene\/fgf23\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296692","article-title":"Iron(III)-hydroxide polymaltose complex in iron deficiency anemia\/review and meta-analysis","volume":"57","author":"Toblli JE","year":"2007","unstructured":"Toblli JE, Brignoli R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia\/review and meta-analysis. Arzneimittelforschung. 2007, 57:431-38. 10.1055\/s-0031-1296692","journal-title":"Arzneimittelforschung"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2019.1593006","article-title":"Safety profile of iron polymaltose infusions","volume":"47","author":"Lee AY","year":"2019","unstructured":"Lee AY, Leung SH. Safety profile of iron polymaltose infusions. Hosp Pract (1995). 2019, 47:96-98. 10.1080\/21548331.2019.1593006","journal-title":"Hosp Pract (1995)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094217","article-title":"Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women-PREFER a randomized, placebo-controlled study","volume":"9","author":"Favrat B","year":"2014","unstructured":"Favrat B, Balck K, Breymann C, Hedenus M, Keller T, Mezzacasa A, Gasche C. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women-PREFER a randomized, placebo-controlled study. PLoS One. 2014, 9:e94217. 10.1371\/journal.pone.0094217","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2042018816678363","article-title":"Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature","volume":"8","author":"Bishay RH","year":"2017","unstructured":"Bishay RH, Ganda K, Seibel MJ. Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature. Ther Adv Endocrinol Metab. 2017, 8:14-9. 10.1177\/2042018816678363","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/270093-intravenous-iron-iii-hydroxide-polymaltose-complex-infusion-related-severe-prolonged-hypophosphatemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:29:40Z","timestamp":1740821380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/270093-intravenous-iron-iii-hydroxide-polymaltose-complex-infusion-related-severe-prolonged-hypophosphatemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.79868","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}